J7648 Isoetharine (HCPCS) Reimbursement & Policy | OpenPayer

Summary & Overview

HCPCS J7648: Isoetharine HCl Inhalation Solution, Concentrated per mg

HCPCS Level II code J7648 designates isoetharine hydrochloride inhalation solution, an FDA-approved, non-compounded concentrated product billed per milligram and administered through durable medical equipment. As a drug-specific HCPCS J-code, J7648 matters nationally because it standardizes billing for this inhaled bronchodilator when supplied via DME, affecting coverage determinations, claims processing, and payer-provider reimbursement workflows across commercial and public payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for isoetharine inhalation therapy, typical sites of service (home and outpatient settings using DME), and the administrative implications of using a HCPCS Level II J-code for per-milligram billing. The publication outlines what to expect in claims submission and payer review, and highlights where Data not available in the input prevents presentation of specific benchmarks, utilization metrics, or payer-specific coverage policies.

This summary is intended for clinicians, billing professionals, and policy analysts seeking a national-level briefing on the billing designation and operational considerations associated with HCPCS Level II code J7648.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ7648HCPCS Level IIisoetharineinhalation solutiondurable medical equipmentdrug billingJ-coderespiratory therapy

Billing Code Overview

HCPCS Level II code J7648 represents Isoetharine hydrochloride inhalation solution, an FDA-approved, non-compounded, concentrated formulation billed per milligram. The product is intended for inhalation and is supplied as a solution to be administered through durable medical equipment (DME).

Service Type: Medication administration via durable medical equipment (inhalation solution, concentrated form, per mg)

Typical Site of Service: Home or outpatient settings where DME respiratory equipment is used

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with a history of chronic obstructive pulmonary disease and intermittent bronchospasm presents to a durable medical equipment (DME) supplier for on-site administration of a concentrated inhalation bronchodilator. The medication is J7648 (isoetharine hydrochloride, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per milligram). Clinical workflow: the ordering clinician documents the indication (acute bronchospasm or maintenance bronchodilator therapy) and prescribes the precise milligram dose; the prescription is transmitted to the DME vendor. At the DME visit, a respiratory therapist or qualified clinician verifies patient identity, reviews current respiratory status, confirms inhaler/nebulizer compatibility, prepares the concentrated solution per manufacturer instructions, and administers the dose via the patient’s nebulizer or DME-delivered inhalation device. Vital signs and response (respiratory rate, oxygen saturation, peak expiratory flow or wheeze improvement) are recorded before and after administration. Any adverse reactions are documented and communicated to the prescribing provider. Billing uses J7648 per milligram for the administered isoetharine; appropriate modifiers are appended to reflect unusual circumstances (e.g., increased procedural services, discontinued service, or bilateral procedures) as applicable. Typical sites of service include outpatient DME supplier locations, outpatient infusion or respiratory treatment clinics, and home health settings where DME staff deliver therapy. Typical patient scenario: older adult with COPD or reactive airways disease experiencing bronchospasm requiring a concentrated inhaled beta-agonist administered through DME with monitoring by respiratory therapy staff and billing of J7648 per milligram.

Coding Specifications

HCPCS J7328: Hyaluronan (gelsyn-3) Intra‑articular Injection, 0.1 mg

HCPCS-J7650-ISOETHARINE-INHALATION-UNIT-DOSE-DME

HCPCS J7650: Isoetharine HCl Inhalation Solution, Unit-Dose, DME

HCPCS-J7682-TOBRAMYCIN-INHALATION-SOLUTION-300MG-UNIT-DOSE-DME

HCPCS J7682: Tobramycin Inhalation Solution, 300 mg Unit Dose

HCPCS-J1737-MELOXICAM-INJECTION-1MG

HCPCS J1737: Meloxicam (azurity) Injection, 1 mg

HCPCS-J1747-SPESOLIMAB-INJECTION-1MG

HCPCS Level II J1747: Injection, spesolimab-sbzo, 1 mg

HCPCS-J1120-ACETAZOLAMIDE-INJECTION-500MG

HCPCS Level II J1120: Injection, Acetazolamide Sodium, up to 500 mg

HCPCS-J7186-ANTIHEMOPHILIC-FACTOR-VIII-VWF-COMPLEX-INJECTION

HCPCS J7186: Antihemophilic Factor VIII/vWF Complex Injection

HCPCS-J7329-HYALURONAN-TRIVISC-INTRA-ARTICULAR-INJECTION-1MG

HCPCS J7329: Hyaluronan (Trivisc) Intra-articular Injection, 1 mg

HCPCS-J8655-NETUPITANT-PALONOSETRON-ORAL-ANTIEMETIC

HCPCS J8655: Netupitant 300 mg and Palonosetron 0.5 mg, Oral

HCPCS-J7615-LEVALBUTEROL-INHALATION-SOLUTION-COMPOUNDED-UNIT-DOSE-0-5-MG

HCPCS J7615: Levalbuterol Inhalation Solution, Compounded Unit Dose 0.5 mg

Showing 1–10 of 991

`22`	Increased procedural services	Use when additional clinical staff time or complexity beyond typical administration of `J7648` is documented and justified.
`23`	Unusual anesthesia	Use if anesthesia services are required unusually for inhalation administration (rare).
`52`	Reduced services	Use when the full service (medication administration) is partially reduced or not completed as planned.
`53`	Discontinued procedure	Use when administration of `J7648` is started but discontinued for patient safety or adverse reaction.
`54`	Surgical care only	Generally not applicable; include only if a portion of perioperative care relates to medication administration responsibilities.
`55`	Postoperative management only	Generally not applicable; include only if DME staff provide post-procedure medication management separate from initial administration.
`56`	Preoperative management only	Rarely used; include only if medication ordering/administration is limited to preoperative preparation.
`62`	Two surgeons	Use if two qualified clinicians perform jointly required procedures related to administration or monitoring of therapy.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery	Use if an advanced practice clinician assists in the administration or complex monitoring when allowed by payer policy.
`CQ`	Services provided by a registered nurse in an ambulatory infusion setting	Use when a registered nurse in an ambulatory infusion/respiratory setting administers the inhalation therapy under applicable rules.
`QX`	Service performed by an auxiliary under qualified supervision	Use when a certified respiratory therapist or auxiliary performs the administration under required supervision.
`QY`	Service performed by an assistant at surgery (physician assistant, etc.)	Use when applicable assistant provider bills per payer rules for participation in the service.
`SH`	Outpatient service of a split/shared visit	Use when the visit and medication administration are split/shared between physician and non-physician practitioner per payer rules.
`TG`	Anesthesia by an anesthesiologist medically directing two, three, or four concurrent procedures	Rare for inhalation administration; use only if concurrent anesthesiology direction applies.

Taxonomy Code	Specialty	Notes
`respiratory`	Respiratory Therapy	Primary clinicians delivering inhaled DME therapies and monitoring response.
`341600000X`	Pulmonology	Pulmonologists prescribe bronchodilator regimens and oversee complex cases.
`207R00000X`	Internal Medicine	Primary care and hospitalists managing COPD/asthma and ordering inhaled medication via DME.
`363L00000X`	Nurse Practitioner	NPs in outpatient clinics or home health who may order and supervise administration.
`312600000X`	General Practice	General practitioners managing chronic respiratory disease and coordinating DME services.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J44.9`	Chronic obstructive pulmonary disease, unspecified	Common indication for inhaled bronchodilators like isoetharine administered through DME for acute exacerbations or symptomatic relief.
`J45.909`	Unspecified asthma, uncomplicated	Asthma with bronchospasm is a frequent reason for inhaled beta-agonist administration via DME devices.
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	Severe bronchospasm managed in conjunction with inhaled bronchodilators during acute episodes requiring DME support.
`R06.2`	Wheezing	Symptom code often documented alongside administration of inhaled bronchodilator `J7648`.
`J98.01`	Acute bronchospasm	Direct clinical indication for concentrated inhaled beta-agonist therapy delivered through DME.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`94640`	Pressurized or handheld inhaler administration	Often performed alongside `J7648` when bronchodilator is given via an inhaler rather than nebulizer; documents administration service.
`94664`	Demonstration and/or evaluation of patient utilization of an aerosol generator	Performed before or after `J7648` administration to teach or assess correct device use for DME-delivered inhalation therapy.
`94002`	Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted ventilation	May be performed in severe respiratory compromise where inhaled bronchodilator administration via DME is part of broader respiratory management.
`99070`	Supplies and materials (except spectacles), non-covered items	Used to bill for additional supplies related to administration through DME when payers allow separate supply reimbursement.
`94667`	Continuous positive airway pressure ventilation (CPAP) initiation and management	May be part of comprehensive outpatient respiratory treatment sessions where `J7648` is administered as adjunct therapy.

OpenPayer